{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:07:02Z","timestamp":1791486422007,"version":"4.3.4"},"reference-count":84,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000222","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000222","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.cjca.2020.03.020","type":"journal-article","created":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T12:14:09Z","timestamp":1584965649000},"page":"1362-1371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Pediatric Dyslipidemia\u2014Beyond Familial Hypercholesterolemia"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3637-5467","authenticated-orcid":false,"given":"Julieta","family":"Lazarte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Hegele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2020.03.020_bib1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/35025203","article-title":"Atherosclerosis","volume":"407","author":"Lusis","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.cjca.2020.03.020_bib2","first-page":"65","article-title":"Lipids in children and links to adult vascular disease","volume":"39","author":"Coakley","year":"2018","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.cjca.2020.03.020_bib3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrg2481","article-title":"Plasma lipoproteins: genetic influences and clinical implications","volume":"10","author":"Hegele","year":"2009","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.cjca.2020.03.020_bib4","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S2213-8587(19)30264-5","article-title":"Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement","volume":"8","author":"Hegele","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.cjca.2020.03.020_bib5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.metabol.2018.11.005","article-title":"Obesity and dyslipidemia","volume":"92","author":"Vekic","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.cjca.2020.03.020_bib6","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/MOL.0000000000000643","article-title":"Strategies to alter the trajectory of atherosclerotic cardiovascular disease","volume":"30","author":"Packard","year":"2019","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.cjca.2020.03.020_bib7","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.1542\/peds.2009-2107C","article-title":"Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: summary report","volume":"128","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.cjca.2020.03.020_bib8","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1001\/jama.2016.9852","article-title":"Screening for lipid disorders in children and adolescents: US Preventive Services task force recommendation statement","volume":"316","author":"Bibbins-Domingo","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2020.03.020_bib9","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1093\/eurheartj\/ehv157","article-title":"Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment","volume":"36","author":"Wiegman","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2020.03.020_bib10","first-page":"1553","article-title":"Canadian Cardiovascular Society position statement on familial hypercholesterolemia: update 2018","volume":"34","author":"Brunham","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2020.03.020_bib11","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S2213-8587(13)70191-8","article-title":"The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management","volume":"2","author":"Hegele","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.cjca.2020.03.020_bib12","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrendo.2015.26","article-title":"Chylomicronaemia\u2014current diagnosis and future therapies","volume":"11","author":"Brahm","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.cjca.2020.03.020_bib13","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3390\/nu5030981","article-title":"Hypertriglyceridemia","volume":"5","author":"Brahm","year":"2013","journal-title":"Nutrients"},{"key":"10.1016\/j.cjca.2020.03.020_bib14","article-title":"Familial chylomicronemia syndrome: an under-recognized cause of severe hypertriglyceridaemia","author":"Baass","year":"2019","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.cjca.2020.03.020_bib15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/eurheartj\/ehz785","article-title":"Clinical review on triglycerides","volume":"41","author":"Laufs","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2020.03.020_bib16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/1476-511X-10-157","article-title":"Incidence of pancreatitis, secondary causes, and treatment of patients referred to a specialty lipid clinic with severe hypertriglyceridemia: a retrospective cohort study","volume":"10","author":"Sandhu","year":"2011","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.cjca.2020.03.020_bib17","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/joim.12925","article-title":"Conservative management in hypertriglyceridemia-associated pancreatitis","volume":"286","author":"Berberich","year":"2019","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.cjca.2020.03.020_bib18","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jacl.2018.03.093","article-title":"Clinical and biochemical features of different molecular etiologies of familial chylomicronemia","volume":"12","author":"Hegele","year":"2018","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.cjca.2020.03.020_bib19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1139\/Y09-005","article-title":"Novel LPL mutations associated with lipoprotein lipase deficiency: two case reports and a literature review","volume":"87","author":"Rahalkar","year":"2009","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.cjca.2020.03.020_bib20","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.pathol.2018.10.014","article-title":"The role of genetic testing in dyslipidaemia","volume":"51","author":"Berberich","year":"2019","journal-title":"Pathology"},{"key":"10.1016\/j.cjca.2020.03.020_bib21","doi-asserted-by":"crossref","first-page":"626","DOI":"10.7326\/M19-0203","article-title":"The chylomicronemia syndrome is most often multifactorial: a narrative review of causes and treatment","volume":"170","author":"Chait","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cjca.2020.03.020_bib22","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1161\/CIRCRESAHA.118.313171","article-title":"Lipid-lowering agents","volume":"124","author":"Hegele","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2020.03.020_bib23","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1056\/NEJMoa1715944","article-title":"Volanesorsen and triglyceride levels in familial chylomicronemia syndrome","volume":"381","author":"Witztum","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2020.03.020_bib24","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJMc1705994","article-title":"ANGPTL3 inhibition in homozygous familial hypercholesterolemia","volume":"377","author":"Gaudet","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2020.03.020_bib25","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1194\/jlr.R700004-JLR200","article-title":"Lipodystrophies: windows on adipose biology and metabolism","volume":"48","author":"Hegele","year":"2007","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.cjca.2020.03.020_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199052","article-title":"Causes of death in patients with Berardinelli-Seip congenital generalized lipodystrophy","volume":"13","author":"Lima","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.cjca.2020.03.020_bib27","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1530\/JOE-18-0120","article-title":"Biochemical and clinical aspects of glycogen storage diseases","volume":"238","author":"Ellingwood","year":"2018","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.cjca.2020.03.020_bib28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MOL.0000000000000482","article-title":"Polygenic influences on dyslipidemias","volume":"29","author":"Dron","year":"2018","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.cjca.2020.03.020_bib29","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jacl.2018.10.006","article-title":"Severe hypertriglyceridemia is primarily polygenic","volume":"13","author":"Dron","year":"2019","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.cjca.2020.03.020_bib30","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature09270","article-title":"Biological, clinical and population relevance of 95 loci for blood lipids","volume":"466","author":"Teslovich","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.cjca.2020.03.020_bib31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/MOL.0000000000000576","article-title":"The evolution of genetic-based risk scores for lipids and cardiovascular disease","volume":"30","author":"Dron","year":"2019","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.cjca.2020.03.020_bib32","doi-asserted-by":"crossref","first-page":"360","DOI":"10.7326\/L17-0182","article-title":"Polygenic risk for hypertriglyceridemia can mimic a major monogenic mutation","volume":"167","author":"Stahel","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cjca.2020.03.020_bib33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/MOL.0000000000000579","article-title":"Editorial: designing targeted sequencing panels for dyslipidemia","volume":"30","author":"Hegele","year":"2019","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.cjca.2020.03.020_bib34","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/joim.12727","article-title":"Secondary causes of chylomicronemia: defining the underside of the iceberg","volume":"283","author":"Berberich","year":"2018","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.cjca.2020.03.020_bib35","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.atherosclerosis.2018.12.019","article-title":"Chylomicronemia: Differences between familial chylomicronemia syndrome and multifactorial chylomicronemia","volume":"283","author":"Paquette","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cjca.2020.03.020_bib36","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1210\/er.2014-1062","article-title":"Hypertriglyceridemia in the genomic era: a new paradigm","volume":"36","author":"Lewis","year":"2015","journal-title":"Endocr Rev"},{"key":"10.1016\/j.cjca.2020.03.020_bib37","first-page":"X","article-title":"Familial combined hyperlipoproteinemia","volume":"7","author":"Genest","year":"1991","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2020.03.020_bib38","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/MOL.0000000000000270","article-title":"Combined hyperlipidemia: familial but not (usually) monogenic","volume":"27","author":"Brahm","year":"2016","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.cjca.2020.03.020_bib39","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/MOL.0000000000000068","article-title":"Familial combined hyperlipidemia: from molecular insights to tailored therapy","volume":"25","author":"van Greevenbroek","year":"2014","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.cjca.2020.03.020_bib40","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0045-9380(94)90010-8","article-title":"Familial combined hyperlipidemia in children: clinical expression, metabolic defects, and management","volume":"24","author":"Cortner","year":"1994","journal-title":"Curr Probl Pediatr"},{"key":"10.1016\/j.cjca.2020.03.020_bib41","doi-asserted-by":"crossref","first-page":"53B","DOI":"10.1016\/0002-9149(95)80012-H","article-title":"Dense low density lipoproteins and coronary artery disease","volume":"75","author":"Krauss","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2020.03.020_bib42","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/MOL.0000000000000590","article-title":"The biochemical and genetic diagnosis of lipid disorders","volume":"30","author":"Schaefer","year":"2019","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.cjca.2020.03.020_bib43","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1093\/hmg\/ddp361","article-title":"A\u00a0polygenic basis for four classical Fredrickson hyperlipoproteinemia phenotypes that are characterized by hypertriglyceridemia","volume":"18","author":"Hegele","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cjca.2020.03.020_bib44","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1161\/ATVBAHA.111.226365","article-title":"An increased burden of common and rare lipid-associated risk alleles contributes to the phenotypic spectrum of hypertriglyceridemia","volume":"31","author":"Johansen","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cjca.2020.03.020_bib45","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/MOL.0b013e3283471972","article-title":"Genetic bases of hypertriglyceridemic phenotypes","volume":"22","author":"Johansen","year":"2011","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.cjca.2020.03.020_bib46","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.jacl.2015.04.009","article-title":"Familial hypercholesterolemia in children and adolescents: a clinical perspective","volume":"9","author":"de Ferranti","year":"2015","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.cjca.2020.03.020_bib47","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11883-017-0667-9","article-title":"Genetics of triglycerides and the risk of atherosclerosis","volume":"19","author":"Dron","year":"2017","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.cjca.2020.03.020_bib48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2020.03.020_bib49","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/MOL.0000000000000499","article-title":"The journey toward understanding lipoprotein(a) and cardiovascular disease risk: are we there yet?","volume":"29","author":"Boffa","year":"2018","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.cjca.2020.03.020_bib50","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jacl.2019.04.010","article-title":"Use of lipoprotein(a) in clinical practice: a biomarker whose time has come. A scientific statement from the National Lipid Association","volume":"13","author":"Wilson","year":"2019","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.cjca.2020.03.020_bib51","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.jacl.2018.08.012","article-title":"Lipoprotein(a) and secondary prevention of atherothrombotic events: a critical appraisal","volume":"12","author":"Boffa","year":"2018","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.cjca.2020.03.020_bib52","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1194\/jlr.R060582","article-title":"Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?","volume":"57","author":"Boffa","year":"2016","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.cjca.2020.03.020_bib53","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/10408363.2017.1415866","article-title":"Lipoprotein(a) in clinical practice: new perspectives from basic and translational science","volume":"55","author":"Scipione","year":"2018","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.cjca.2020.03.020_bib54","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1056\/NEJMoa1905239","article-title":"Lipoprotein(a) reduction in persons with cardiovascular disease","volume":"382","author":"Tsimikas","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2020.03.020_bib55","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/MOL.0000000000000549","article-title":"RNA-targeted therapeutics for lipid disorders","volume":"29","author":"Tsimikas","year":"2018","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.cjca.2020.03.020_bib56","series-title":"Lipid screening in childhood and adolescence for detection of familial hypercholesterolemia: a systematic evidence review for the U.S. Preventive Services Task Force","author":"Lozano","year":"2016"},{"key":"10.1016\/j.cjca.2020.03.020_bib57","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jacl.2019.09.008","article-title":"Type 1 diabetes is associated with an increase in cholesterol absorption markers but a decrease in cholesterol synthesis markers in a young adult population","volume":"13","author":"Semova","year":"2019","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.cjca.2020.03.020_bib58","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/ncpcardio0638","article-title":"Genetic determinants of the metabolic syndrome","volume":"3","author":"Pollex","year":"2006","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1016\/j.cjca.2020.03.020_bib59","doi-asserted-by":"crossref","first-page":"700","DOI":"10.2310\/JIM.0b013e3181d844f7","article-title":"Phenomics: expanding the role of clinical evaluation in genomic studies","volume":"58","author":"Lanktree","year":"2010","journal-title":"J\u00a0Investig Med"},{"key":"10.1016\/j.cjca.2020.03.020_bib60","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/pch\/15.2.77","article-title":"Promoting optimal monitoring of child growth in Canada: using the new World Health Organization growth charts","volume":"15","author":"Val\u00e9rie","year":"2010","journal-title":"Paediatr Child Health"},{"key":"10.1016\/j.cjca.2020.03.020_bib61","first-page":"117","article-title":"Longitudinal evaluation of the prevalence of overweight\/obesity in children with congenital heart disease","volume":"31","author":"Tamayo","year":"2015","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2020.03.020_bib62","first-page":"595","article-title":"The atherogenic dyslipidemia complex and novel approaches to cardiovascular disease prevention in diabetes","volume":"34","author":"Stahel","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2020.03.020_bib63","first-page":"124","article-title":"Cardiovascular consequences of childhood obesity","volume":"31","author":"McCrindle","year":"2015","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2020.03.020_bib64","first-page":"105","article-title":"Obesity\u2014it must not remain the neglected risk factor in cardiology","volume":"31","author":"Poirier","year":"2015","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2020.03.020_bib65","first-page":"642","article-title":"Abdominal obesity and cardiovascular disease: is inflammation the missing link?","volume":"28","author":"Despres","year":"2012","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2020.03.020_bib66","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1152\/physrev.00033.2011","article-title":"Pathophysiology of human visceral obesity: an update","volume":"93","author":"Tchernof","year":"2013","journal-title":"Physiol Rev"},{"key":"10.1016\/j.cjca.2020.03.020_bib67","doi-asserted-by":"crossref","first-page":"E242","DOI":"10.25011\/cim.v36i5.20123","article-title":"Devastating metabolic consequences of a life of plenty: focus on the dyslipidemia of overnutrition","volume":"36","author":"Lewis","year":"2013","journal-title":"Clin Invest Med"},{"issue":"Suppl 1","key":"10.1016\/j.cjca.2020.03.020_bib68","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000329163","article-title":"Screening and treatment of dyslipidemias in children and adolescents","volume":"76","author":"Daniels","year":"2011","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.cjca.2020.03.020_bib69","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/jama.2016.9671","article-title":"Lipid screening in children and adolescents","volume":"316","author":"Urbina","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2020.03.020_bib70","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ypmed.2013.08.010","article-title":"An overview of national clinical guidelines for the management of childhood obesity in primary care","volume":"57","author":"Richardson","year":"2013","journal-title":"Prev Med"},{"key":"10.1016\/j.cjca.2020.03.020_bib71","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/MOL.0000000000000611","article-title":"Update on low-density lipoprotein cholesterol quantification","volume":"30","author":"Chung","year":"2019","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.cjca.2020.03.020_bib72","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2020.03.020_bib73","doi-asserted-by":"crossref","first-page":"17093","DOI":"10.1038\/nrdp.2017.93","article-title":"Familial hypercholesterolaemia","volume":"3","author":"Defesche","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.cjca.2020.03.020_bib74","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2020.03.020_bib75","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/MOL.0000000000000614","article-title":"Non-HDL cholesterol should not generally replace LDL cholesterol in the management of hyperlipidaemia","volume":"30","author":"Soran","year":"2019","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.cjca.2020.03.020_bib76","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/MOL.0000000000000644","article-title":"Can atherosclerosis be cured?","volume":"30","author":"Wilkins","year":"2019","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.cjca.2020.03.020_bib77","first-page":"1263","article-title":"2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult","volume":"32","author":"Anderson","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2020.03.020_bib78","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0076-6879(88)59010-9","article-title":"cAMP export and its regulation by prostaglandin A1","volume":"159","author":"Brunton","year":"1988","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.cjca.2020.03.020_bib79","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/MOL.0000000000000067","article-title":"The composition and metabolism of large and small LDL","volume":"25","author":"Diffenderfer","year":"2014","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.cjca.2020.03.020_bib80","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/HCO.0000000000000410","article-title":"Small, dense LDL: an update","volume":"32","author":"Gerber","year":"2017","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.cjca.2020.03.020_bib81","doi-asserted-by":"crossref","first-page":"48i","DOI":"10.1016\/S0002-9149(02)02633-4","article-title":"How, when, and why to use apolipoprotein B in clinical practice","volume":"90","author":"Sniderman","year":"2002","journal-title":"Am J Cardiol"},{"issue":"suppl A","key":"10.1016\/j.cjca.2020.03.020_bib82","first-page":"24A","article-title":"Apolipoprotein B and apolipoprotein AI as predictors of coronary artery disease","volume":"4","author":"Sniderman","year":"1988","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2020.03.020_bib83","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2015.10.055","article-title":"Discordance between apolipoprotein B and LDL-cholesterol in young adults predicts coronary artery calcification: the CARDIA study","volume":"67","author":"Wilkins","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2020.03.020_bib84","article-title":"Eradicating the burden of atherosclerotic cardiovascular disease by lowering apolipoprotein B lipoproteins earlier in life","volume":"7","author":"Robinson","year":"2018","journal-title":"J\u00a0Am Heart Assoc"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X20302750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X20302750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:42:57Z","timestamp":1760107377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X20302750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":84,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0828282X20302750"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2020.03.020","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pediatric Dyslipidemia\u2014Beyond Familial Hypercholesterolemia","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2020.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}